Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian High Grade Serous Adenocarcinoma × Paracentesis × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Malignant Ascites 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian High Grade Serous Adenocarcinoma 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Paracentesis 1 Biopsy 1 Atovaquone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05998135 2025-09-11

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Emory University

Phase 2 Recruiting

Ovarian High Grade Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡